(R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol
C25H28F3N3O — CID 166525275
Data last refreshed: (MolForge compound catalog, from PubChem)
About (R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol
(R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol (PubChem CID 166525275) has the molecular formula C25H28F3N3O and a molecular weight of 443.51 g/mol. Its IUPAC name is (R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol.
Molecular Properties
| Compound Name | (R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol |
|---|---|
| PubChem CID | 166525275 |
| Molecular Formula | C25H28F3N3O |
| Molecular Weight | 443.51 g/mol |
| Exact Mass | 443.22 |
| IUPAC Name | (R)-(1,3-dimethylazetidin-3-yl)-(4-propan-2-ylphenyl)-[5-[3-(trifluoromethyl)pyrrol-1-yl]-3-pyridinyl]methanol |
| SMILES | CC(C)c1ccc([C@](O)(c2cncc(-n3ccc(C(F)(F)F)c3)c2)C2(C)CN(C)C2)cc1 |
| InChI | InChI=1S/C25H28F3N3O/c1-17(2)18-5-7-19(8-6-18)24(32,23(3)15-30(4)16-23)21-11-22(13-29-12-21)31-10-9-20(14-31)25(26,27)28/h5-14,17,32H,15-16H2,1-4H3/t24-/m0/s1 |
| InChIKey | HBBVYPLTJIQKGS-DEOSSOPVSA-N |
| XLogP | 5.20 |
| TPSA | 41.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.51 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166525275 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.